Also known as
Alpha, alpha-meth, indopan, amtrak, amthrax, trymene, 164E, 3-IT, IT-290, IT-403, αMT
Classification
Psychedelic, hallucinogenic
Overview
AMT (Alpha-methyltryptamine) is a stimulanta drug that acts on the Central Nervous System, increasing some rates of function such as heart-rate of the tryptamine type. It was originally investigated for its anti-depressant properties, but the effects proved disappointing and it was soon abandoned. Some people take it for its stimulating effects 1.
AMT (or αMT) is a long-acting psychedelic and euphoric synthetic stimulanta drug that acts on the Central Nervous System, increasing some rates of function such as heart-rate that is chemically related to the tryptamines and effectually similar to amphetamines. Although it was quickly disregarded as a pharmaceutical product, AMT quickly gained a small but enduring reputation as a recreational stimulanta drug that acts on the Central Nervous System, increasing some rates of function such as heart-rate and continues to be used in waves of popularity. Due to its very slow onset and low dose thresholds users must be very cautious when first using it 1.
aMT is a powerful hallicinogen with some simulant effects that can make you –
- feel euphoric, upbeat and friendly to those around you,
- see illusions/distorted perceptions (and sometimes frightening hallucinationswhere someone sees, hears, smells, tastes or feels things that don't exist outside of their mind when you see and hear things that aren’t there),
- feel anxious and panicky 2.
aMT is very active in small doses which means it’s easy to take too much and overdose, this can lead to you becoming agitated and having bad experiences like anxiety attacks.
aMT was tested as a potential antidepressant in the 1960s but there is actually little information about its harms, especially any long-term harm. It’s difficult to know how any regular users will be affected if they use it for a long time.
There is also a slight risk that aMT will react with other medicines and a range of foods to cause dangerous increases in blood pressure (for example, certain SSRIselective serotonin reuptake inhibitor. More anti-depressants, some wines and cheeses, or with Bovril or Marmite) 2.
A stimulanta drug that acts on the Central Nervous System, increasing some rates of function such as heart-rate and psychoactive drug which produces effects similar to 3,4-methylenedioxy-N-methylamphetamine (MDMASee Ecstasy More), despite being structurally dissimilar 3.
Medical usage
None!
What does it look like?
Why take it?
Sought after effects
- stimulationcan be defined as any changes in a person's energy levels which are interpreted as stimulating and encouraging when it comes to movement and physical activities such as running, walking, cleaning, socializing, dancing, and climbing More,
- mood enhancement,
- empathogenic properties,
- occasional audio and visual experiences 1.
Undesired effects
- anxiety,
- nervousness,
- blurred vision,
- nausea,
- vomiting (common),
- tension headaches,
- occasional muscular aches 1.
Dosage
Pharmacology
Alpha-methyltryptamine is a variant of tryptamine with a methyl substituent on the alpha carbon. It acts as both a MAOI (monoamine oxidase inhibitor), which is how it was first proposed to work as an anti-depressant, and as a non-selective serotonin receptor agonist. It appears to work relatively equally as a reuptake inhibitor and releasing agent of the main three monoamines (dopamine, norepinephrine and serotonin).
Despite similarities in effect to MDMASee Ecstasy More, they are not chemically closely related, with AMT having a similar relationship to tryptamine as amphetamine has to phenethylamine.
AMT is pharmacologically active at doses as low as 5mg and it can take as long as 3 hours for the initial effects to be felt when used recreationally, meaning inexperienced users are sometimes at risk of believing the substance has not worked and re-dosing too early 1.
αMT’s psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist.
αMT also acts as a releasing agent of serotonin, noradrenaline, and dopamine 7, 8. It also acts as a very weak, non-selective RIMA in-vitrooutside the body 9 and in-vivowithin the living organism 10, but this is unlikely to be very significant (if at all) with common doses.
However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive 4.
Lethal dosage
Toxicity
- Long lasting serotonin neuro-toxicity at high doses is potentially possible, and is seen with a close analogue of alpha-methyltryptmaine: alpha-ethyltryptamine 3.
Mode of use
Swallowed (either in wraps or capsules) or insufflatedInsufflating, commonly referred to as snorting, is a method of drug administration where powdered substances are inhaled through the nose. More, very rarely smoked/vaped 1. The capsules and pellets are swallowed and the powder can be dissolved in water or other drinks, snorted, bombedwrapped in a cigarette paper and swallowed or smoked 2.
Effects
Physical effects
- pupil dilation,
- spontaneous physical sensations,
- stimulationcan be defined as any changes in a person's energy levels which are interpreted as stimulating and encouraging when it comes to movement and physical activities such as running, walking, cleaning, socializing, dancing, and climbing More,
- difficulty urinating,
- headaches,
- increased blood pressure,
- increased heart rate,
- increased perspiration,
- nausea 4.
Cognitive effects
- cognitive euphoriastate of intense well-being, happiness, and excitement More,
- conceptual thinking,
- time distortion,
- analysis enhancementbest described as a subtle to distinct enhancement of one's overall ability to process information and logically or creatively analyse concepts, ideas and scenarios. The experience of this leads onto deep and complex states of contemplation which often result in an abundance of new and insightful ideas. This gives the person a powerful ability to dissect and rationally analyse concepts and problems, allowing them to gain insights and reach new conclusions, perspectives and solutions which would have been otherwise difficult to conceive of. More,
- emotionality enhancement,
- immersion enhancementThis is an effect which can be described as a pronounced increase in one's ability to become fully engulfed within external visual or auditory stimuli such as music, movies, video games and various other forms of media. More,
- increased music appreciation,
- thought acceleration,
- thought connectivity,
- wakefulness,
- memory suppression 4.
Visual effects
- acuity enhancement,
- colour enhancement,
- pattern recognition enhancement,
- after images,
- colour shifting,
- drifting,
- scenery slicingbest described as an effect which only occurs spontaneously and rarely sustains itself for more than several seconds. The experience of this effect splits the visual field into separate sections. These individual slices then proceed to drift slowly away from their original position before disappearing and resetting to normality. More,
- symmetrical texture repetition,
- tracers,
- geometrybest described as the experience of a person's field of vision being partially or completely encompassed by fast-moving, colourful and indescribably complex geometric patterns, form constants, phosphenes, shapes, fractals, structures and colour. These geometric forms can also become structured and organised in a way that presents genuine information to the person experiencing it far beyond the perception of meaningless, although complex, shapes and colours. This happens through the experience of innately understood geometric representations that feel as though they depict specific concepts and neurological components that exist within the brain in a manner that is extremely detailed. More,
- autonomous entities,
- internal hallucinationsbest described as the perception of imagery and scenes which are experienced exclusively within a layer in front of one's open or closed eye vision and not seamlessly within the external environment around oneself. At lower levels, internal hallucinations begin with imagery which does not take up the entirety of one's visual field and is distinctively separate from its background. These can be described as spontaneous moving or still images of scenes, concepts, places, and anything one could imagine. They are manifested in varying levels of detail, ranging from ill-defined and cartoon-like in nature to completely realistic and beyond realism through seemingly impossible, non-euclidean geometric forms. They rarely hold their form for more than a few seconds before fading or shifting into another image. More,
- perspective alterations,
- scenarios and plots,
- settings, sceneries, and landscapes,
- transformations 4.
Auditory effects
- auditory distortion,
- auditory enhancement,
- auditory hallucinationswhere someone sees, hears, smells, tastes or feels things that don't exist outside of their mind 4.
Positive
- increase in energy,
- mood lift, smiling,
- visual patterning and closed eye visuals,
- increased awareness and appreciation of music,
- empathogenic qualities 6.
Neutral
- general change in consciousness (as with most psychoactives),
- blurred vision,
- restlessness,
- yawning,
- dilated pupils,
- decreased appetite,
- dry mouth, overstimulated taste, and resulting difficulty eating,
- extreme, vision-obscuring visuals at high doses : “obnoxiously visual” 6.
Risks
Like any drug, taking aMT does involve risks. Here’s what it may do to you –
- you might feel anxious, restless or aggressive,
- you might feel unwell, like you have a fever, have abnormal sweating, vomit or you may have a headache,
- your heart may beat very quickly or irregularly which can be dangerous,
- aMT can cause hallucinationswhere someone sees, hears, smells, tastes or feels things that don't exist outside of their mind which means you may see or hear things that aren’t there. This can sometimes be quite scary and confusing known as a bad trip. Good trips can be amusing and pleasant but you can’t be sure whether you’ll have a good or bad tripa disturbing hallucinogenic experience that can cause users to feel extremely anxious and threatened More,
- you might be at risk of harm as a result of fear and hallucinationswhere someone sees, hears, smells, tastes or feels things that don't exist outside of their mind,
- it is easy to overdose on aMT because compared to many other powder drugs, you only need to take a small amount for it to have a substantial effect,
- there is a small possibility that aMT may react with certain medicines and some foods (like certain wines and cheeses, or with Bovril or Marmite). This can cause a dangerous rise in blood pressure,
- we know that some drugs can irritate and damage the lining of the nose, stomach and lungs depending on how they are taken. aMT may cause similar damage but more research is needed to see whether this is the case 2.
Interactions
Dangerous
Caution
- Cannabis – Cannabis has an unexpectedly strong and somewhat unpredictable synergy with psychedelics. Small amounts can reduce nausea with aMT but take care.
- Caffeine – High doses of caffeine may cause anxiety which is less manageable when tripping, and since both are stimulating the combination may cause some physical discomfort.
- Alcohol – aMT has a broad mechanism of action in the brain and so does alcohol so the combination can be unpredictable 5.
Legality
- aMT became a Class A drug In January 2015. This means that it is illegal to have for yourself, give away or sell –
- possession of aMT can get you up to seven years in jail and/or an unlimited fine,
- supplying someone else, even your friends, with aMT can get you up to life imprisonment and/or an unlimited fine 2.
What if you’re caught?
- If the Police catch you with aMT, they’ll always take some action. This could include a formal caution, arrest and prosecution.
- A conviction for a drug-related offence could have a serious impact. It can stop you visiting certain countries – for example the United States – and limit the types of jobs you can apply for 2.
Did you know?
- mixing drugs with driving is illegal and can be very dangerous. It may lead to you having an accident and injuring yourself or your friends,
- you could still be unfit to drive the day after using aMT,
- you can get a heavy fine, be disqualified from driving or even go to prison if you take aMT and it affects how you drive 2.
Harm reduction
AMT is active at very low doses (under 10mg) when taken orally, and individual tolerancethis is the process by which the receptors in your brain become habituated to the action of a drug. When tolerance is reached, more of the drug is required to achieve the same effect. With benzodiazepines, and probably with many other classes of drugs as well, tolerance is virtually always associated with some degree of physical dependence. If you find that you are experiencing tolerance, this is a clear warning sign that you may have formed a dependence. More will depend on factors such as age, sex, weight and frequency of use. It also takes far longer than similar substances to take effect, with the onset often not happening for greater than one hour. It is therefore extremely important not to assume that you’ve taken a dud and re-dose too quickly.
When smoked (which is rare), AMT is active at even lower doses, as little as 2 – 5mg, but will take effect quicker (usually within half an hour).
It is fairly common for AMT to produce sensations of nausea, and these can quite often lead to vomiting, particularly amongst inexperienced users. If this happens to you or someone you are with, make sure they are conscious and able to respond (if not make sure they do not swallow their vomit and call an ambulance) and try to get them to drink some water to replace lost fluids.
As it is so long-acting, it is not uncommon for the main effects to continue for many hours, possibly into the following day, after consumption. If someone is still under the effect of the substance make sure they do not drive or operate machinery, and if possible keep them resting until they have fully come down.
AMT acts as a weak MAOI, so be especially careful if you are taking any anti-depressants, and do not take with any other MAOIsMAOIs may be used to treat the symptoms of depression. More.
As with all illegal substances –
Mixing with other drugs and alcohol should be avoided or kept within the user’s own known limits.
Be aware that sharing with friends is a serious offence.
Try not to use alone – at the very least make sure someone knows where you are, and don’t use alone in a locked room or isolated place 1.
History
It was first experimented with in the 1960’s by The Upjohn Company (now a subsidiary of Pfizer Pharmaceuticals) but the results were disappointing and interest was soon dropped. It continued to be marketed for some time in the Soviet Union under the trade name Indopan but had fallen out of use by the 1970’s.
As a recreational drug its use remained very marginal from the 1960’s – 90’s, when it experienced an upsurge in popularity linked to the clubbing scene and other stimulant-type drugs associated with that subculture. It was deemed significant enough to be scheduled in the US in 2003 but due to remaining relatively uncommon in Europe remained uncontrolled in the UK until 2015 1.
It was originally developed in the USA in the 60’s by the Upjohn company during research into anti-depressants, and the alpha-ethylated homologue became available as a commercial anti-depressant in the US (under the name Monase). However, αMT itself was available during the 60’s for use as an anti-depressant in 5 and 10mg doses in the Soviet Union, sold under the brand name Indopan.
As with many research chemicals it was examined by Alexander Shulgin and details of its effects and synthesis were described in the book TiHKAL. Both during his own experiences noted in the entry, and in his further notes drawing from the experiences of others he concludes that the chemical seems to have a wide variation in many of its properties between users and even individual experiences – particularly in effects and onset.
It was one of the first ‘research chemicals’ which became widely available on the internet during the 1990’s, and as a result became illegal in the USA in 2003. The drug remained relatively obscure up until this point, though it was used in certain psychotherapeutic studies during the 60’s, and there are some reports which suspect recreational use took place as early as the 1960’s, as a result of the chemical supply for these studies being diverged.
With the rising popularity of research chemical use on the internet during the 21st century, it has seen increasing levels of use – and while it remains legal in most countries in the world recent efforts have been made by certain governments to illegalise it 6.
Footnotes:
AMT, 2017, http://www.release.org.uk/drugs/amt
AMT, 2017, http://www.talktofrank.com/drug/amt
Alpha-methyltryptamine, 2017, https://www.drugbank.ca/drugs/DB01446
AMT, 2017, https://psychonautwiki.org/wiki/AMT
αMT, 2017, http://drugs.tripsit.me/amt
AMT, 2017, https://wiki.tripsit.me/wiki/AMT
Nagai, F. and Nonaka, R. and Satoh Hisashi Kamimura, K., The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain, European Journal of Pharmacology, 2007, 559, 2-3, 132-137, https://doi.org/10.1016/j.ejphar.2006.11.075, http://www.sciencedirect.com/science/article/pii/S0014299906013811
Nonaka, R. and Nagai, F. and Ogata, A. and Satoh, K., In Vitro Screening of Psychoactive Drugs by [35S]GTPγS Binding in Rat Brain Membranes, Biological and Pharmaceutical Bulletin, 2007, 30, 12, 2328-2333, https://www.jstage.jst.go.jp/article/bpb/30/12/30_12_2328/_article
Arai, Y. and Toyoshima, Y. and Kinemuchi, H., Studies of Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase II. Inhibition by α-Methylated Substrate-Analogue Monoamines, α-Methyltryptamine, α-Methylbenzylamine and Two Enantiomers of α-Methylbenzylamine, The Japanese Journal of Pharmacology, 1986, 41, 2, 191-197, http://doi.org/10.1254/jjp.41.191, https://www.jstage.jst.go.jp/article/jphs1951/41/2/41_2_191/_article
Greig, M. E. and Walk, R. A. and Gibbons, A. J., The effect of three tryptamine derivatives on serotonin metabolism in vitro and in vivo, Journal of Pharmacology and Experimental Therapeutics, 1959, 127, 2, 110-115, http://jpet.aspetjournals.org/content/127/2/110.short